DavidRobertMollerMD

PubMed

• Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.
  Stern, B. J.,Royal, W.,Gelfand, J. M.,Clifford, D. B.,Tavee, J.,Pawate, S.,Berger, J. R.,Aksamit, A. J.,Krumholz, A.,Pardo, C. A.,Moller, D. R.,Judson, M. A.,Drent, M....> ;JAMA Neurol. 2018 Sep 01
• Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.
  Gordon Cooke, I. Kamal, M. Strengert, Emily Hams, Leona Mawhinney, Aisling Tynan, Ciaran O’Reilly, David N O'Dwyer, S L Kunkel, Ulla G. Knaus, Denis C. Shields, David ...> ;QJM: An International Journal of Medicine. 2018 Apr 1
• Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
  Kruse, M. J.,Kovell, L.,Kasper, E. K.,Pomper, M. G.,Moller, D. R.,Solnes, L.,Chen, E. S.,Schindler, T. H.> ;JACC Cardiovasc Imaging. 2017 Jan 23
• Etiologies of Sarcoidosis.
  Chen, E. S.,Moller, D. R.> ;Clin Rev Allergy Immunol. 2015 Mar 17
• 3 citations
  Negative clinical trials in sarcoidosis: failed therapies or flawed study design?
  Moller, D. R.> ;The European respiratory journal. 2014 Nov 2
• "Sarcoidosis: recent advances".
  Müller-Quernheim, J., Prasse, A., Moller, D. R.> ;Seminars in respiratory and critical care medicine. 2014 Jul 10
• Etiologic role of infectious agents.
  Chen, E. S.,Moller, D. R.> ;Semin Respir Crit Care Med. 2014 Jul 10
• Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
  Nadera J. Sweiss, Wei Zhang, Beverly S. Franek, Silvia N. Kariuki, David R. Moller, Karen C. Patterson, Peggy Bennett, Lakshmi R. Girijala, Vaisak Nair, Robert P. Baug...> ;PLOS ONE. 2011 Dec 14
• Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.
  Edward S. Chen, Zhimin Song, Matthew H. Willett, Shannon Heine, Rex C. Yung, Mark C. Liu, Steve D. Groshong, Ying Zhang, Rubin M. Tuder, David R. Moller> ;American Journal of Respiratory and Critical Care Medicine. 2010 Feb 15
• Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations.
  Sweiss, N.J., Salloum, R., Gandhi, S., Ghandi, S., Alegre, M., Sawaqed, R., Badaracco, M., Pursell, K., Pitrak, D., Baughman, R.P., Moller, D.R., Garcia, J.N., Niewold...> ;PLoS One. 2010
• Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.
  Barnett, C.F., Bonura, E.J., Nathan, S.D., Ahmad, S., Shlobin, O.A., Osei, K., Zaiman, A.L., Hassoun, P.M., Moller, D.R., Barnett, S.D., Girgis, R.E.> ;Chest. 2009-06-01
• T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.
  Chen, E. S., Wahlström, J., Song, Z., Willett, M. H., Wikén, M., Yung, R. C., West, E. E., McDyer, J. F., Zhang, Y., Eklund, A., Grunewald, J., Moller, D. R.> ;J Immunol. 2008-12-15
• Etiology of sarcoidosis.
  Chen, E.S., Moller, D.R.> ;Clin Chest Med. 2008 Sep
• Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
  Pipeling, M.R., West, E.E., Osborne, C.M., Whitlock, A.B., Dropulic, L.K., Willett, M.H., Forman, M., Valsamakis, A., Orens, J.B., Moller, D.R., Lechtzin, N., Migueles...> ;J Immunol. 2008 Jul 1
• 22 citations
  Potential etiologic agents in sarcoidosis.
  Moller, D. R.> ;Proceedings of the American Thoracic Society. 2007 Aug 9
• Expression Profiling in Granulomatous Lung Disease
  Edward S. Chen, David R. Moller> ;Proceedings of the American Thoracic Society. 2007 Jan 1
• Genome-wide search for sarcoidosis susceptibility genes in African Americans.
  Michael C. Iannuzzi, Sudha K. Iyengar, Courtney Gray-McGuire, Robert C. Elston, Robert P. Baughman, James F. Donohue, Kathryn Hirst, Marc A. Judson, Mani S. Kavuru, Ma...> ;Genes and Immunity. 2005 Sep 1
• A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study.
  Benjamin A. Rybicki, Kathryn Hirst, Sudha K. Iyengar, Juliana Barnard, Marc A. Judson, Cecile S. Rose, James F. Donohue, Mani S. Kavuru, David L. Rabin, Milton D. Ross...> ;Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2005 Jun 1
• Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.
  Song, Z., Marzilli, L., Greenlee, B.M., Chen, E.S., Silver, R.F., Askin, F.B., Teirstein, A.S., Zhang, Y., Cotter, R.J., Moller, D.R.> ;J Exp Med. 2005 Mar 7
• A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors
  Lee S. Newman, Cecile S. Rose, Eddy A. Bresnitz, Milton D. Rossman, Juliana Barnard, Margaret Frederick, Michael L. Terrin, Steven E. Weinberger, David R. Moller, Geof...> ;American Journal of Respiratory and Critical Care Medicine. 2004 Dec 15
• Two year prognosis of sarcoidosis: The ACCESS experience
  Marc A. Judson, Robert P. Baughman, B. Thompson, Alvin S. Teirstein, Michael L. Terrin, Milton D. Rossman, Henry Yeager, Geoffrey McLennan, Eddy A. Bresnitz, Louis DeP...> ;Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2003 Oct 1
• Pulmonary fibrosis of sarcoidosis. New approaches, old ideas.
  David R. Moller> ;American Journal of Respiratory Cell and Molecular Biology. 2003 Sep 1
• Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?
  Moller, D.R., Chen, E.S.> ;Am J Respir Cell Mol Biol. 2002 Oct
• What causes sarcoidosis
  David R. Moller, Edward S. Chen> ;Current Opinion in Pulmonary Medicine. 2002 Sep 1
• Thalidomide for chronic sarcoidosis.
  Baughman, R.P., Judson, M.A., Teirstein, A.S., Moller, D.R., Lower, E.E.> ;Chest. 2002 Jul
• Join now to see all

Abstracts/Posters

• Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living TherapeuticsTM Products
  David Moller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019